Elucidating Wenshen Xuanbi Decoction's Anti‐Osteoporotic Mechanisms via Integrated Multiomics Analysis
Biomedical Chromatography · 2026
DOI: 10.1002/bmc.70273 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2026. Verfasst von Hu Jianbo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics and Traumatology, Suqian Affiliated Hospital of Nanjing University of Chinese Medicine, Suqian, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Osteoporosis. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Project of Clinical Research on Key Diseases of Traditional Chinese Medicine in Suqian Hospital of Traditional Chinese Medicine.
Abstract (Originalsprache)
This study aimed to systematically investigate the active components and therapeutic mechanisms of Wenshen Xuanbi Decoction (WSXBT) against primary osteoporosis (POP) using an integrated multi‐omics approach. HPLC‐Q‐TOF‐MS/MS analysis identified 28 chemical constituents in WSXBT. Through network pharmacology, transcriptomic profiling (GSE35958), single‐cell RNA sequencing (GSE147287), and weighted gene co‐expression network analysis (WGCNA), we identified 15 core targets of WSXBT against POP, with CTNNB1 and AKT1 emerging as the top candidates. Enrichment analyses revealed that these targets are involved in key biological processes, such as cellular senescence, osteoclast differentiation, Wnt signaling, and the PI3K‐Akt pathway. Molecular docking and dynamics simulations confirmed stable binding between key WSXBT components (e.g., glycyrrhizic acid) and the core targets AKT1 and CTNNB1. Our findings suggest that WSXBT exerts its anti‐osteoporotic effects by modulating the PI3K‐AKT and Wnt signaling pathways, thereby promoting osteogenesis and inhibiting osteoclastogenesis. This study provides a scientific basis for the clinical application of WSXBT and advances the understanding of multi‐target mechanisms underlying traditional Chinese medicine compound actions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics and Traumatology, Suqian Affiliated Hospital of Nanjing University of Chinese Medicine, Suqian, China.
- Suqian Hospital, Nanjing Drum Tower Hospital Group, Suqian, China.
- Department of Orthopedics, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China.
ORCID-Profile: Hu Jianbo, Hu Yuan, Sun Jiahao, Shen Jirong
Förderung
- Project of Clinical Research on Key Diseases of Traditional Chinese Medicine in Suqian Hospital of Traditional Chinese Medicine
Zitieren
APA
Jianbo, H., Yuan, H., Jiahao, S., & Jirong, S. (2026). Elucidating Wenshen Xuanbi Decoction's Anti‐Osteoporotic Mechanisms via Integrated Multiomics Analysis. Biomedical Chromatography. https://doi.org/10.1002/bmc.70273
Vancouver
Jianbo H, Yuan H, Jiahao S, Jirong S. Elucidating Wenshen Xuanbi Decoction's Anti‐Osteoporotic Mechanisms via Integrated Multiomics Analysis. Biomedical Chromatography. 2026. doi:10.1002/bmc.70273
BibTeX
@article{Jianbo2026,
author = {Jianbo, Hu and Yuan, Hu and Jiahao, Sun and Jirong, Shen},
title = {Elucidating Wenshen Xuanbi Decoction's Anti‐Osteoporotic Mechanisms via Integrated Multiomics Analysis},
journal = {Biomedical Chromatography},
year = {2026},
doi = {10.1002/bmc.70273}
}
EUVIMED